Gabapentin in the acute treatment of refractory bipolar disorder

Bipolar Disorders

Volumn 1, Issue 1, 1999, Pages 61-65

  Altshuler, Lori L ^e   Keck Jr , Paul E ^a   McElroy, Susan L ^a   Suppes, Trisha ^b   Brown, E Sherwood ^b   Denicoff, Kirk ^c   Frye, Mark ^c   Gitlin, Michael ^f   Hwang, Sun ^f   Goodman, Robyn ^f   Leverich, Gabriele ^c   Nolen, Williem ^d   Kupka, Ralph ^d   Post, Robert ^c  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^d (SFBN) HC Rumke Group   (Netherlands)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f NONE

Author keywords

Bipolar disorder; Gabapentin; Treatment

Indexed keywords

4 AMINOBUTYRIC ACID; ACETIC ACID DERIVATIVE; AMINE; CYCLOHEXANECARBOXYLIC ACID DERIVATIVE; GABAPENTIN; TRANQUILIZER;

ACUTE DISEASE; ADULT; ARTICLE; BIPOLAR DISORDER; CLINICAL TRIAL; FEMALE; HUMAN; MALE; PROSPECTIVE STUDY; TIME; TREATMENT OUTCOME;

ACETIC ACIDS; ACUTE DISEASE; ADULT; AMINES; ANTIMANIC AGENTS; BIPOLAR DISORDER; CYCLOHEXANECARBOXYLIC ACIDS; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; PROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 0033188208     PISSN: 13985647     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-5618.1999.10113.x     Document Type: Article

References (24)

1. McElroy SL, Keck PE Jr. Drugs for treatment of bipolar disorder: anticonvulsants. In: Nemeroff CB, Schatzberg AF, eds. Textbook of Psychopharmacology. Washington, DC: American Psychiatric Press, 1995; 351-356.
2. UK Gabapentin Study Group. Gabapentin in partial epilepsy. Lancet 1990; 335: 1114-1117.
3. Bruin J, Sanders M, Anhut H et al. Efficacy and safety of gabapentin (Neurontin): a multicenter, placebo-controlled, double-blind study. Neurology 1991; 41 (Suppl 1): 330-331.
4. U.S. Gabapentin Study Group No. 5. Gabapentin as add-on therapy in refractory partial epilepsy: a double-blind, placebo-controlled, parallel group study. Neurology 1993; 43: 2292-2298.
5. Browne TR for the International, UK, and US Gabapentin Study Groups. Efficacy and safety of gabapentin. In: Chadwick D, ed. New Trends in Epilepsy Management: The role of Gabapentin Royal Society of Medicine Services International Congress and Symposium Services, No. 198. London: Royal Society of Medicine Services, 1993; 47-57.
6. Chadwick D. Gabapentin: clinical use. In: Levy RH, Mattson RH, Meldrum BS, eds. Antiepileptic Drugs, 4th edn. New York: Raven Press, 1995; 851-856.
7. Petroff OA, Rothman DL, Behar KL, Lamoureux D, Mattson RH. The effect of gabapentin on brain gamma-aminobutyric acid in patients with epilepsy. Ann Neurol 1996; 39: 95-99.
8. Taylor CP. Gabapentin: mechanism of action. In: Levy RH, Mattson RH, Meldrum BS, eds. Antiepileptic Drugs, 4th edn. New York: Raven Press, 1995; 829-841.
9. Petty F. GABA and mood disorders: a brief review and hypothesis. J Affect Disord 1995; 34: 275-281.
10. McLean MJ. Gabapentin: chemistry, absorption, distribution, and excretion. In: Levy RH, Mattson RH, Meldrum BS, eds. Antiepileptic Drugs, 4th edn. New York: Raven Press, 1995; 843-849.
11. Ramsay RE. Gabapentin: toxicity. In: Levy RH, Mattson RH, Meldrum BS, eds. Antiepileptic Drugs, 4th edn. New York: Raven Press, 1995; 857-860.
12. Schaffer CB, Schaffer LC. Gabapentin in the treatment of bipolar disorder. Am J Psychiatry 1997; 154: 291-292.
13. Stanton SP, Keck PE, McElroy SL. Treatment of acute mania with gabapentin. Am J Psychiatry 1997; 154: 287.
14. McElroy SL, Soutullo CA, Keck PE Jr, Kmetz GF. A pilot trial of adjunctive gabapentin in the treatment of bipolar disorder. Ann Clin Psychiatry 1997; 9: 99-103.
15. Ghaemi SN, Katzow JA, Desai SP, Goodwin FK. Gabapentin treatment of mood disorders: a preliminary study. J Clin Psychiatry 1998 (in press).
16. Young LT, Robb JC, Patelis-Siotis I, MacDonald C, Joffee R. Acute treatment of bipolar depression with gabapentin. Biol Psychiatry 1997; 42: 851-853.
17. Ryback RS, Brodsky L, Munasifi F. Gabapentin in bipolar disorder (letter). J Neuropsychiatry Clin Neurosci 1997; 2: 301.
18. Bennett J, Goldman WT, Suppes T. Gabapentin for treatment of bipolar and schizoaffective disorders (letter). J Clin Psychopharmacol 1998; 17: 141-142.
19. Frye MA, Ketter TA, Kimbrell TA, Cora-Locatellii G, Dunn RT, Post RM. Gabapentin and lamotrigine monotherapy in mood disorder. Presented at the 150th Annual Meeting of the American Psychiatric Association, Symposium 33C, May 17-22, 1997, San Diego, CA.
20. Marcotte DB, Fogelman L, Wolfe N, Nemire R. Gabapentin: an effective therapy for patients with bipolar disorder. Presented at the 150th Annual Meeting of the American Psychiatric Association, Abstract NR261, May 17-22, 1997, San Diego, CA.
21. Guy W, ed. Clinical global impressions. In: ECDEU Assessment Manual for Psychopharmacology. Rockville, MD: National Institute of Mental Health, 1976.
22. Spearing MK, Post RM, Leverich GS et al. Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP). The CGI-BP. Psychiatry Res 1997; 73: 159-171.
23. Knoll J, Stegman K, Suppes T. Clinical experience using gabapentin adjunctively in patients with a history of mania or hypomania. J Affect Disord 1998; 49: 229-233.
24. Frye MA, Kimbrell TA, Dunn RT, Piscitelli S, Grothe D, Vanderham E, Cora-Locatelli G, Post RM, Ketter TA. Gagapentin does not alter single dose lithium pharmacokinetics. J Clin Psychopharmacol 1998; 18: 461-464.